Request Trial

Pharma news

Reset all filters
Geography
Company
Refine search
Fed Circ written description ruling overturns $1.2 billion award
Americas
Fed Circ written description ruling overturns $1.2 billion award
Kite Pharma has successfully persuaded the US Court of Appeals for the Federal Circuit to reverse a $1.2 billion win for the Bristol-Meyers Squibb owned Juno Therapeutics over a cancer treatment patent.   26 August 2021
Regeneron asks court to dismiss COVID-19 tech patent suit
Pharma
Regeneron asks court to dismiss COVID-19 tech patent suit
Regeneron wants a Manhattan district court to toss a lawsuit that claims it infringed on patents in the development and testing of COVID-19 treatments.   24 August 2021
WHO issues fresh warning over fake COVID vaccines
Africa
WHO issues fresh warning over fake COVID vaccines
The World Health Organization has identified counterfeit versions of the Covishield vaccine in India and Uganda.   20 August 2021
Americas
Nexus and Nevakar face off over hypotension drug
Nexus Pharmaceuticals and rival Nevakar have gone to court to determine which company has the right to sell a new hypotension drug, which can be administered to patients under anesthesia during surgery.   19 August 2021
Americas
Mylan asks SCOTUS to end NHK-Fintiv rule
Mylan Laboratories has urged the US Supreme Court to overturn the controversial NHK-Fintiv rule, claiming that it is “unlawful”.   16 August 2021
Pharma
Judge: Roche subsidiaries shouldn’t dodge DNA patent suit
A Delaware magistrate judge has said that Roche subsidiaries should not be able to dismiss a suit claiming they infringed two DNA patents.   12 August 2021
Pharma
FTC urges Congress to step in over AbbVie antitrust claim
The US Federal Trade Commission has dropped its remaining claim in a lawsuit against AbbVie and Besins Healthcare, after the US Supreme Court declined to rule that consumers had a right to be compensated by the companies.   3 August 2021
Pharma
US Judiciary Committee advances four bills to curb antitrust pharma practices
The US Senate Judiciary Committee has unanimously voted to pass four bills that aim to crack down on anti-competitive practices in the pharmaceutical industry.   3 August 2021
Pharma
Is big pharma’s antidote to the COVID-19 waiver a viable alternative?
In May, a consortium of pharmaceutical companies came together to pitch a new plan to help provide more equitable access to COVID-19 vaccines.   29 July 2021
Americas
PTAB grants inter partes review of China’s firm’s Alzheimer’s patent
The US Patent Trial and Appeal Board has given the go-ahead for an inter partes review of a Chinese pharma company’s US patent related to a treatment for Alzheimer’s.   22 July 2021